SCHEMBL8767689

SCHEMBL8767689

CC/C(=C(\c1ccc(I)cc1)c1ccc(OCCCCl)cc1)c1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 16/20 0.76
PDE1B Q01064 16/20 0.76
PDE1C Q14123 16/20 0.76
ESR1 P03372 3/20 0.67
ESR2 Q92731 2/20 0.67
CYP3A4 P08684 2/20 0.65
CYP19A1 P11511 1/20 0.65
MEN1 O00255 1/20 0.62
NPC1 O15118 1/20 0.62
NR1I2 O75469 1/20 0.62
PRKD3 O94806 1/20 0.62
ABCB11 O95342 1/20 0.62
EGFR P00533 1/20 0.62
GBA1 P04062 1/20 0.62
NR3C1 P04150 1/20 0.62
ERBB2 P04626 1/20 0.62
TP53 P04637 1/20 0.62
PRKCG P05129 1/20 0.62
CYP1A2 P05177 1/20 0.62
PRKCB P05771 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767701 1.00 PDE1A (0.76) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8767710 1.00 PDE1A (0.76) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8768184 0.96 PDE1A (0.76) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8768173 0.96 PDE1A (0.76) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8768178 0.96 PDE1A (0.76) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL8652566 0.95 PDE1A (0.77) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL10349389 0.95 PDE1A (0.73) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL10608838 0.95 PDE1A (0.73) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL10349388 0.95 PDE1A (0.73) PDE1APDE1BPDE1CESR1ESR2
SCHEMBL10774708 0.93 CYP19A1 (0.74) PDE1APDE1BPDE1CESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638064-B1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECH GROUP (GB) 1997-08-13 EP disclosed
US-5589500-A TREATMENT OF TUMORS OR ANTICARCINOGENIC AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-12-31 US disclosed
EP-0638064-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER. BRITISH TECH GROUP (GB) 1995-02-15 EP disclosed
WO-1993022275-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECHNOLOGY GROUP LTD (GB) 1993-11-11 WO disclosed